Latest return on equity
CNS Pharmaceuticals Return on equity
Direct answer
CNS Pharmaceuticals's return on equity is -106.62%.
The verified market snapshot reports -106.62%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 5, 2026.
Get free CNS Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -106.62%